Federal solicitation · ARPA-H-SOL-26-147 · back to recent
One Comprehensive Universal Radiotherapy for Everyone (1-CURE)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · NAICS 541714 · Deadline 2026-05-22T23:59:00-04:00
Solicitation description
Amendment 4: Revised Appendix B: Full Proposal Content and Instructions to consistently state that Volume I, Element H is the Target Product Profiles (TPP). Appendix B Volume I, Element I was renamed to Milestone Payment Schedule (MPS) and clarifies that the provided format in Appendix I, Attachment 3 is to be used. Appendix B Volume II Cost and Pricing Data Support page limit was removed. Appendix L: Cost Proposal Spreadsheet with Resource Sharing has been added to the attachments. Amendment 3: Revised Appendix F: Administrative & National Policy Requirements Document, Section 3, Paragraph 1, to state that the Biographical Common Form, the Current and Pending (other) Support Common Form, and the Collaborators and Other Affiliations attachments may be provided during the negotiation phase after proposal selection. Amendment 2: Added Appendices J & K under the Attachments section. Amendment 1: Added Appendices A - I separately under the Attachments section. The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the One Comprehensive Universal Radiotherapy for Everyone (1-CURE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the attached 1-CURE_ISO_ARPA-H-SOL-26-147 and its Appendices A - C. Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-152, for information regarding the 1-CURE Proposers’ Day. Special Notice, ARPA-H-SN-26-152, is an independent announcement and is not attached to this ISO announcement. All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the 1-CURE Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQs page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/1-cure/faqs
Similar opportunities
Other open SAM.gov opportunities under the same NAICS, prioritizing the same buying agency.
| Title | Agency | Est. value | Basis |
|---|---|---|---|
| Strategic Marburg Advanced Research and Development,... | HEALTH AND HUMAN... | $1,042.1M | same agency naics |
| Biomedical Advanced Research and Development Authority... | HEALTH AND HUMAN... | $99.7M | same agency naics |
| R & D to develop Execabase to combat S. aureus | HEALTH AND HUMAN... | $86.8M | same agency naics |
| BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003) | HEALTH AND HUMAN... | $7.5M | same agency naics |
| NIH Tetramer Core Facility | HEALTH AND HUMAN... | - | same agency naics |
| AI-Enabled Discovery of Broad-Spectrum Small-Molecule... | HEALTH AND HUMAN... | - | same agency naics |
| Statistical and Data Coordinating Center (SDCC) for... | HEALTH AND HUMAN... | - | same agency naics |
| Notice of Intent to Sole Source - Chemistry Center for... | HEALTH AND HUMAN... | - | same agency naics |
Data this profile does NOT cover
- No likely incumbent surfaced; the solicitation number did not prefix-match any award in the FPDSAward window.
- No FPDSAward rows for NAICS 541714 in the trailing 12 months; vendor concentration unavailable.